Saturday 17 October 2026
Export CSLT’s income statement to Excel — free account
Castlight Health, inc.
CSLT Healthcare Health Information Services
Operating cash flow growth for ten consecutive years.
2.05
0.00
0.00%
Follow CSLT
| Sep '21 | Jun '21 | Mar '21 | Dec '20 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.77 | 2.93 | 1.66 | 1.34 | |
P/FCF ratio |
12.56 | 24.07 | 17.10 | 0.00 | |
P/Operating CF |
43.33 | 90.41 | 31.25 | 66.55 | |
P/B ratio |
1.99 | 3.34 | 1.90 | 1.59 | |
Price to Tangible BV |
3.13 | 5.36 | 3.11 | 2.65 | |
EV/Sales |
1.38 | 2.58 | 1.35 | 1.11 | |
EV/EBITDA |
28.92 | 42.41 | 26.56 | 30.29 | |
EV/Operating CF |
9.34 | 20.58 | 11.79 | (29.17) | |
EV/FCF |
9.74 | 21.20 | 13.94 | (17.75) | |
Quick Ratio |
2.73 | 2.57 | 2.31 | 2.36 | |
Current Ratio |
2.94 | 2.84 | 2.50 | 2.47 | |
Net Debt/EBITDA |
(38.04) | (62.84) | (124.45) | (13.55) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.86 | 0.85 | 0.82 | 0.72 | |
Operating CF/Net income |
(2.87) | (1.94) | (2.53) | (2.47) | |
Capex/Depreciation |
(0.13) | (0.01) | (0.06) | (0.03) | |
Research and Development Expense of Revenue |
33.45% | 34.59% | 34.55% | 30.79% | |
Selling, General and Administrative Expense of Revenue |
38.17% | 38.13% | 37.88% | 38.07% | |
Intangible Assets out of Total Assets |
0.28 | 0.29 | 0.29 | 0.30 | |
Share Based Compensation of Revenue |
9.20% | 8.90% | 8.86% | 7.78% | |
Graham Net Nets |
0.23 | 0.13 | 0.20 | 0.21 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.82%) | (1.90%) | (3.97%) | (32.31%) | |
Free Cash Flow Yield |
7.96% | 4.16% | 5.85% | (4.64%) | |
Revenue per Share |
0.22 | 0.22 | 0.22 | 0.24 | |
Operating CF per Share |
0.04 | 0.03 | 0.05 | 0.02 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.03 | 0.03 | 0.05 | 0.02 | |
Cash per Share |
0.41 | 0.38 | 0.36 | 0.33 | |
Shareholders Equity per Share |
0.79 | 0.79 | 0.79 | 0.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.79 | 0.79 | 0.79 | 0.82 | |
Free Cash Flow |
5.38 | 4.59 | 7.36 | 2.81 | |
Working Capital |
63.46 | 59.06 | 53.04 | 50.47 | |
Capital Expenditures |
(0.46) | (0.03) | (0.21) | (0.15) | |
Net Current Asset Value |
58.84 | 54.30 | 46.53 | 41.88 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
26.88 | 27.46 | 31.55 | 31.57 | |
Average Payables |
4.62 | 6.17 | 8.84 | 12.37 | |
Average Assets |
166.16 | 167.19 | 173.41 | 204.78 | |
Average Common Equity |
124.57 | 122.21 | 122.23 | 148.37 |
Columns are period end dates